Ernexa Therapeutics Inc. (ERNA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 10M | 3.13M | 3.38M | 4.79M | 2.21M | 2.35M | 4.73M | 3.58M | 6.16M | 9.6M | 7.03M | 3.89M |
| Cash & Short-Term Investments | 9.18M | 1.88M | 3.05M | 4.32M | 1.92M | 1.73M | 4.26M | 2.59M | 5.12M | 7.58M | 4.55M | 1.84M |
| Cash Only | 9.18M | 1.88M | 3.05M | 4.32M | 1.92M | 1.73M | 4.26M | 2.59M | 5.12M | 7.58M | 4.55M | 1.84M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 95K | 95K | 0 | 154K | 156K | 437K | 187K | 228K | 351K | 425K | 1.78M | 984K |
| Days Sales Outstanding | - | - | - | - | - | 28.7K | 39.2 | 560.52 | 751.23 | 5.96K | 2.49K | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 724K | 1.15M | 153K | 323K | 137K | 186K | 279K | 769K | 697K | 1.6M | 704K | 1.07M |
| Total Non-Current Assets | 547K | 2.7M | 2.79M | 2.79M | 2.85M | 2.92M | 2.99M | 42.9M | 43.49M | 39.53M | 45.22M | 43.06M |
| Property, Plant & Equipment | 437K | 547K | 633K | 631K | 686K | 755K | 824K | 36.64M | 37.23M | 33.27M | 35.03M | 35.55M |
| Fixed Asset Turnover | - | - | - | - | - | 0.00x | 0.03x | 0.00x | 0.00x | 0.00x | 0.00x | - |
| Goodwill | 0 | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.09M | 4.09M | 0 | 4.09M | 0 |
| Other Non-Current Assets | 110K | 110K | 116K | 117K | 118K | 118K | 120K | 120K | 120K | 4.21M | 8.14M | 5.47M |
| Total Assets | 10.54M | 5.83M | 6.17M | 7.58M | 5.06M | 5.27M | 7.72M | 46.49M | 49.66M | 49.13M | 52.25M | 46.95M |
| Asset Turnover | - | - | - | - | - | 0.00x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | - |
| Asset Growth % | 108.4% | 10.72% | -20.03% | -83.69% | -89.81% | -89.28% | -85.23% | -1% | 228.68% | 120.53% | 149.68% | 74.54% |
| Total Current Liabilities | 3.46M | 3.11M | 2.14M | 2.65M | 10.44M | 2.94M | 9.95M | 9.6M | 7.77M | 6.57M | 9.63M | 7.17M |
| Accounts Payable | 1.3M | 1.13M | 958K | 1.32M | 1.27M | 1.72M | 2.19M | 2.19M | 2.06M | 1.07M | 1.46M | 2.67M |
| Days Payables Outstanding | 1.27K | - | - | - | - | - | -3.36K | 2.04K | 236.57 | 1.76K | 1.59K | - |
| Short-Term Debt | 163K | 213K | 0 | 0 | 2.25M | 207K | 776K | 4.27M | 2.87M | 0 | 1.64M | 1.75M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 189K | 189K | 190K | 349K | 0 |
| Other Current Liabilities | 1.49M | 1.77M | 151K | 274K | 5.35M | 12K | 6.66M | 2.81M | 2.44M | 109K | 4.9M | -976K |
| Current Ratio | 2.89x | 1.01x | 1.58x | 1.81x | 0.21x | 0.80x | 0.48x | 0.37x | 0.79x | 1.46x | 0.73x | 0.54x |
| Quick Ratio | 2.89x | 1.01x | 1.58x | 1.81x | 0.21x | 0.80x | 0.48x | 0.37x | 0.79x | 1.46x | 0.73x | 0.54x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 227K | 320K | 458K | 489K | 571K | 630K | 43.16M | 45.41M | 45.3M | 40.33M | 39.06M | 35.92M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 32.04M | 8.89M | 8.01M | 6.77M | 3.45M | 331K |
| Capital Lease Obligations | 226K | 277K | 346K | 376K | 419K | 477K | 534K | 36.04M | 36.56M | 32.85M | 35M | 34.96M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 165K | 0 |
| Other Non-Current Liabilities | 1K | 43K | 112K | 113K | 152K | 153K | 10.59M | 175K | 377K | 307K | 360K | 379K |
| Total Liabilities | 3.68M | 3.43M | 2.6M | 3.14M | 11.01M | 3.57M | 53.11M | 55.01M | 53.07M | 46.9M | 48.69M | 43.09M |
| Total Debt | 389K | 490K | 552K | 593K | 2.88M | 684K | 33.55M | 49.2M | 47.45M | 41.84M | 41.24M | 37.22M |
| Net Debt | -8.79M | -1.39M | -2.5M | -3.72M | 964K | -1.04M | 29.28M | 46.62M | 42.34M | 34.27M | 36.69M | 35.38M |
| Debt / Equity | 0.06x | 0.20x | 0.15x | 0.13x | - | 0.40x | - | - | - | 18.74x | 11.58x | 9.63x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -38.81x | - | - | -0.65x | -14.77x | -5.93x | -7.45x | -14.51x | -48.11x | - |
| Total Equity | 6.86M | 2.4M | 3.57M | 4.44M | -5.95M | 1.7M | -45.39M | -8.53M | -3.41M | 2.23M | 3.56M | 3.87M |
| Equity Growth % | 215.28% | 41.15% | 107.86% | 152.12% | -74.38% | -23.82% | -1374.37% | -320.54% | -146.23% | -81.56% | -59.58% | -73.84% |
| Book Value per Share | 8.66 | 7.64 | 10.85 | 21.45 | -2.79 | 0.83 | -209.76 | -39.40 | -15.77 | 10.32 | 16.46 | 18.23 |
| Total Shareholders' Equity | 6.86M | 2.4M | 3.57M | 4.44M | -5.95M | 1.7M | -45.39M | -8.53M | -3.41M | 2.23M | 3.56M | 3.87M |
| Common Stock | 6K | 39K | 39K | 37K | 262K | 257K | 27K | 27K | 27K | 27K | 27K | 27K |
| Retained Earnings | -251.14M | -245.64M | -244.13M | -242.88M | -239.74M | -231.54M | -225.77M | -199.16M | -193.63M | -186.98M | -180.82M | -175.23M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |